29 Sep Nineteen Wisconsin companies will present at the 7th Annual MidAmerica Healthcare Venture
Nineteen early stage companies from Wisconsin will be among 47 presenting companies at the MidAmerica Healthcare Venture Forum hosted by the Wisconsin Technology Council. The conference brings together CEOs and CFOs of healthcare companies, venture capitalists, corporate business development executives, angel investors, investment bankers, university spin-outs and tech-transfer officers.
This forum is geared specifically to US investors and entrepreneurs of emerging biotech/pharma, medical device, and healthcare technology companies. The event will be held Nov. 11-12 at Madison’s Monona Terrace Community and Convention Center and is expected to once again draw over 300+ attendees.
This year’s company application process was oversubscribed. Selection of the companies was made by a committee of the MidAmerica Health Investors Network. The MidAmerica Healthcare Investors Network, which produces the forum in cooperation with International Business Forum in New York, is an association of 48 venture capital firms from 14 states. Those firms collectively have about $2 billion in assets under management. Each presenting company was also screened by venture firms such as Arboretum Ventures, Triathlon Medical Ventures, CID Capital, Venture Investors, and DaneVest Tech Fund.
In addition to the nineteen companies from Wisconsin, there will be 28 other companies from 14 states. Of the other 28 companies selected to present, eight are from Ohio, six from Michigan, three each from Minnesota and Kentucky, two each from Iowa, Illinois and Indiana, and one each from Kansas and Missouri.
Wisconsin companies selected to present are: Addiction Therapeutix, Inc.; BioSystem Development, LLC; CellCura, Inc.; Cellectar, Inc.; Cellular Dynamics International, Inc.; Compact Particle Acceleration Corp.; Echometrix; EraGen Biosciences, Inc.; Flex Biomedical; FluGen, Inc.; Gentel Biosciences, Inc.; GWC Technologies, Inc.; Mithridion, Inc.; Nerites Corporation; NeuWave Medical; Phoenix Nuclear Labs; Quintessence Biosciences, Inc.; Rapid Diagnostek, Inc.; and Ratio, Inc.
“The strong showing by Wisconsin companies is evidence of the depth and breadth of the state’s early stage economy. We’re pleased that MHIN selected a diverse selection of Wisconsin companies for a spot on their prestigious stage,” said Tom Still, president of the Wisconsin Technology Council. The Tech Council and Forward Wisconsin are local hosts for the conference.